Chanaverm

1 x 2,5 l

Oral solution

Active substance

Levamisole (Levamisol hydrochloride) : 7,5 % w/v

ATC code

QP52AE01 Levamisole

QP52AE Imidazothiazoles

QP52A Anthelmintics

QP52 Anthelmintics

QP Antiparasitic products, insecticides and repellents

Species

Cattle and Sheep

Indications

A broad spectrum anthelmintic for the treatment and control of gastro-intestinal and pulmonary nematode infections in cattle and sheep, effective against mature and developing immature stages of the following levamisole-susceptible major nematode worm species:

Gastro-intestinal Worms: Trichostrongylus spp., Cooperia spp., Ostertagia spp. (except inhibited Ostertagia larvae in cattle), Haemonchus spp., Nematodirus spp., Bunostomum spp., Oesophagostomum spp., Chabertia spp.

Lungworms: Dictyocaulus spp.

Not effective against Type II winter scour.

Dose to be administered and administration route

The product should only be administered as an oral drench. The 500 ml Armadose presentation is for use only with the Armadose worming system. The 1L, 2.5L and 5L presentations are for use with conventional dosing gun systems. Dosing should be carried out accurately, at a dose rate of 7.5 mg Levamisole HCl per kg bodyweight.

To ensure administration of a correct dose, body weight should be determined as accurately as possible; accuracy of the dosing device should be checked.

Dosage guide:

Cattle: 1 ml/10 kg bodyweight		Sheep: 0.5 ml/5 kg bodyweight
Bodyweight	Dose (ml)	Bodyweight	Dose (ml)
50 kg (approx. 1 cwt)	5	10 kg (approx. 22 lb)	1
100 kg (approx. 2 cwt)	10	20 kg (approx. 44 lb)	2
150 kg (approx. 3 cwt)	15	30 kg (approx. 66 lb)	3
200 kg (approx. 4 cwt)	20	40 kg (approx. 88 lb)	4
250 kg (approx. 5 cwt)	25	50 kg (approx. 110 lb)	5
300 kg (approx. 6 cwt)	30	60 kg (approx. 132 lb)	6
Cattle over 300 kg should be given a further 1 ml for each additional 10 kg bodyweight		Sheep over 60 kg should be given a further 0.5 ml for each additional 5 kg bodyweight

Veterinary advice should be sought:

a) on appropriate dosing programmes and stock management to achieve adequate parasite control, and to reduce the likelihood of anthelmintic resistance developing.

b) if the product does not achieve the desired clinical effect, since other diseases, nutritional disturbances or anthelmintic resistance may be involved.

Do not mix with other products.